Virginia Senate Bill SB545

Virginia 2026 Regular Session

• Introduced: 1/14/26
• Refer: 1/14/26

Caption

Ivermectin; authorize over-the-counter sale.

Impact

If enacted, SB545 would significantly change the regulations concerning the sale and distribution of ivermectin within Virginia. The bill represents a shift from the current requirement that mandates a prescription for the purchase of this medication. Proponents of the bill argue that increasing accessibility to ivermectin could provide a critical resource for certain health conditions, thereby improving healthcare options for Virginia residents. However, there are concerns about the implications of such a change regarding patient safety and proper medical guidance.

Summary

Senate Bill 545 aims to amend the Code of Virginia by allowing the over-the-counter sale of ivermectin suitable for human use. Under this proposed law, any person aged 18 years or older would be permitted to purchase ivermectin without a prescription or a consultation with a pharmacist or other healthcare professional. This bill is being introduced as a means to increase accessibility to ivermectin amid discussions regarding its benefits and uses.

Contention

Notable points of contention surrounding SB545 include debates over the safety and efficacy of allowing over-the-counter access to ivermectin. Critics of the bill voice concerns that without proper medical advice, individuals may misuse the drug or ignore significant health risks associated with it. Additionally, the bill brings to light broader discussions around self-medication and the responsibility of regulatory bodies in ensuring public health safety. The potential for misinformation about ivermectin, particularly in the context of its controversial use during health crises, adds to the complexity of the debate.